| Issue Date | Title | Author(s) |
| 2023-07 | Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol. | Date, K; Williams, B; Cohen, J; Chaudhuri, N; Bajwah, S; Pearson, M; Higginson, I; Norrie, J; Keerie, C; Tuck, S; Hall, P; Currow, D; Fallon, M; Johnson, M |
| 2023-04 | Top 10 Tips for Research Grant Writing: A Guide for Nurses and Allied Health Professionals. | Chan, RJ; Hart, NH |
| 2023-06-20 | Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era. | Lai-Kwon, J; Heynemann, S; Hart, NH; Chan, RJ; Smith, TJ; Nekhlyudov, L; Jefford, M |
| 2023-09 | In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells | Paudel, KR; Rajput, R; De Rubis, G; Raju Allam, VSR; Williams, K; Singh, SK; Gupta, G; Salunke, P; Hansbro, PM; Gerlach, J; Dua, K |
| 2023-02-24 | Prevalence and predictors of sleep problems in women following a cancer diagnosis: results from the women's wellness after cancer program. | Edmed, SL; Huda, MM; Smith, SS; Seib, C; Porter-Steele, J; Anderson, D; McCarthy, AL |
| 2023-07-14 | Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1. | Pride, NA; Haebich, KM; Walsh, KS; Lami, F; Rouel, M; Maier, A; Chisholm, AK; Lorenzo, J; Hearps, SJC; North, KN; Payne, JM |
| 2023-08-26 | Breast screening participation and degree of spread of invasive breast cancer at diagnosis in mental health service users, a population linkage study. | Sara, G; Lambeth, C; Burgess, P; Curtis, J; Walton, R; Currow, D |
| 2023-02-24 | Development of a self-management support practice framework for addressing cancer-related fatigue: a modified Delphi study. | Agbejule, OA; Hart, NH; Ekberg, S; Chan, RJ |
| 2023-10 | LBA95 Anamorelin and weight gain in patients with advanced non-small cell lung cancer (NSCLC) and cachexia: Efficacy and safety in the multinational phase III SCALA program | Currow, D; Chessari, S; Bonomi, P; Giorgino, R; Skipworth, R |
| 2023-03-01 | Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD). | Hardy, J; Greer, R; Huggett, G; Kearney, A; Gurgenci, T; Good, P |
